angiotensin ii, des-phe(8)- has been researched along with 2019 Novel Coronavirus Disease in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 44 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apparsundaram, S; Goyal, RK; Kumar, S; Patil, CR; Sahu, S | 1 |
| Boytsova, EB; Lopatina, OL; Morgun, AV; Salmin, VV; Salmina, AB | 1 |
| Colombo, D; Del Nonno, F; Gheblawi, M; Kassiri, Z; MacIntyre, E; Munan, M; Nikhanj, A; O'Neil, C; Oudit, GY; Poglitsch, M; Sligl, W; Wang, K | 1 |
| Javanmardi, K; Soltani Hekmat, A | 1 |
| Bartosova, L; Galis, P; Goncalvesova, E; Klimas, J; Paulis, L; Rajtik, T | 1 |
| Azuelos, I; Baglole, CJ; Eidelman, DH; Haidar, Z; Huang, MJ; Morganstein, T; Trivlidis, J | 1 |
| Arslan, B; Ergun, NU; Kalkan, A; Kocatas, A; Onal, H; Semerci, SY; Suner, N; Topuz, S; Topuzogullari, M; Ugurel, OM; Yoldemir, SA | 1 |
| Abdul Hamid, H; Che Mohd Nassir, CMN; Mustapha, M; Norman, HH; Ramli, MD; Zolkefley, MKI | 1 |
| Ciechanowicz, AK; Kucia, M; Lay, WX; Leszczak, C; Leszczak, S; Prado Paulino, J; Suchocki, E | 1 |
| D'Armiento, JM; Eiseman, KA; Elisman, K; Fonseca, LD; Gerber, A; Goldklang, MP; Wagener, G | 1 |
| Asgharpour, S; Bandala, CR; Chi, LA; Correa-Basurto, J; Martínez-Archundia, M | 1 |
| Bustamante, J; Castellar-Lopez, J; Chang, A; Fernanda Pérez, M; Luna, P; Mendoza-Torres, E; Montoya, Y; Rosales-Rada, W | 1 |
| Apodaca, KD; Barksdale, A; Bernard, GR; Bistran-Hall, AJ; Boyle, K; Brown, SM; Busse, LW; Chen, P; Collins, SP; de Wit, M; DeClercq, J; Douglas, IS; Duggal, A; Files, DC; Gentile, N; Gibbs, KW; Ginde, AA; Hager, DN; Harkins, M; Hudock, KM; Iovine, N; Javaheri, A; Joly, MM; Khan, A; Lanspa, M; Lavieri, R; Levitt, J; Merck, LH; Moskowitz, A; Orr, M; Pulley, J; Puskarich, M; Rice, TW; Rosenberg, Y; Safdar, B; Schildcrout, JS; Schrager, H; Self, WH; Semler, MW; Shotwell, MS; Sturek, JM; Tiffany, B; Troendle, J; Venkateshaiah, L; Vonderhaar, D; Wang, L | 1 |
| Ando, Y; Chiba, Y; Hanazaki, M; Ishizaka, S; Ito, M; Sakai, H; Suto, W; Takenoya, F; Torizuka, A; Ueda, C; Watanabe, C; Yamashita, M | 1 |
| Cheng, H; Wang, GQ; Wang, Y | 1 |
| Moncada, S; Peiró, C | 1 |
| Fei, C; Hao-Ran, C; Hao-Ran, W; Jing, Y; Run-Qian, L; Ya-Bin, L; Yang, G | 1 |
| Aazami, H; Kamali, M; Khoshmirsafa, M; Mansouri, D; Mohsenzadegan, M; Pornour, M; Seif, F | 1 |
| Heffernan, KS; Jae, SY | 1 |
| Mohammed El Tabaa, M | 1 |
| Diamond, B | 1 |
| Pinho, V; Sousa, LP; Teixeira, MM | 1 |
| Beer, JH; Saeedi Saravi, SS | 1 |
| Malek Mahdavi, A | 1 |
| Delpino, MV; Quarleri, J | 1 |
| Motta-Santos, D; Santos, RAS; Santos, SHS | 1 |
| Franco, R; Labandeira-García, JL; Navarro, G; Rivas-Santisteban, R; Rodríguez-Pérez, AI; Serrano-Marín, J | 1 |
| Long, CM; Tan, CS; Yeoh, SF | 1 |
| Gan, R; Georgius, P; Henshaw, DJE; Noble, EP; Rosoman, NP; Sommerfeld, N | 1 |
| Pérez-Vizcaíno, F | 1 |
| Manolis, AA; Manolis, AS; Manolis, TA; Melita, H | 1 |
| Borel, AL; Epaulard, O; Le Gouellec, A; Méry, G; Toussaint, B | 1 |
| Benoit, JL; Benoit, SW; Berger, BA; Henry, BM; Lavie, CJ; Lippi, G; Pulvino, C | 1 |
| Rakugi, H; Takeshita, H; Yamamoto, K | 1 |
| Bogaerts, P; Pucci, F; Rooman, M | 1 |
| Cohen, JB; Edmonston, DL; South, AM; Sparks, MA | 1 |
| Chappell, MC; Gwathmey, TM; Pirro, NT; South, AM | 1 |
| Ahmed, A; Hasan, M; Rahman, MM | 1 |
| Kuriakose, J; Montezano, AC; Touyz, RM | 1 |
| Bernasconi, L; Conen, A; Domenig, O; Gregoriano, C; Haubitz, S; Koch, D; Kutz, A; Mueller, B; Schuetz, P | 1 |
| Nakano, H; Shiina, K; Tomiyama, H | 1 |
| von Bohlen Und Halbach, O | 1 |
| Brouqui, P; Devaux, CA; La Scola, B; Lagier, JC; Meddeb, L; Mege, JL; Melenotte, C; Million, M; Osman, IO; Parola, P; Raoult, D; Stein, A | 1 |
| Barocci, S; Benedetti, S; Canonico, B; Carlotti, E; Montanari, M; Nordi, E; Vandini, D; Zamai, L | 1 |
22 review(s) available for angiotensin ii, des-phe(8)- and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Role of ACE2-Ang (1-7)-Mas axis in post-COVID-19 complications and its dietary modulation.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Cardiovascular Diseases; COVID-19; Dietary Proteins; Flavonoids; Humans; Lung; Peptide Fragments; Plant Oils; Polyphenols; Proto-Oncogene Mas; Terpenes; Virus Internalization; Vitamins | 2022 |
Molecular Mechanisms of Proteins - Targets for SARS-CoV-2 (Review).
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Astrocytes; Basigin; Brain; COVID-19; Humans; Peptide Fragments; SARS-CoV-2; Serine Endopeptidases | 2021 |
Alamandine: Potential Protective Effects in SARS-CoV-2 Patients.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Humans; Oligopeptides; Peptide Fragments; Renin-Angiotensin System | 2021 |
Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; COVID-19; Humans; Hypoxia; Lung; Myocardial Infarction; Peptide Fragments; Renin-Angiotensin System; SARS-CoV-2 | 2021 |
Involvement of the ACE2/Ang-(1-7)/MasR Axis in Pulmonary Fibrosis: Implications for COVID-19.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Cannabis; Cigarette Smoking; COVID-19; Fibrosis; Humans; Idiopathic Pulmonary Fibrosis; Inflammation; Lung; Pandemics; Peptide Fragments; Proto-Oncogene Mas; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Risk Factors; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |
Neuroinflammation and COVID-19 Ischemic Stroke Recovery-Evolving Evidence for the Mediating Roles of the ACE2/Angiotensin-(1-7)/Mas Receptor Axis and NLRP3 Inflammasome.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; COVID-19; Humans; Inflammasomes; Ischemic Stroke; Neuroinflammatory Diseases; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Fragments; Proteins; Proto-Oncogene Mas; SARS-CoV-2; Signal Transduction | 2022 |
Potential of Angiotensin-(1-7) in COVID-19 Treatment.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Humans; Pandemics; Peptidyl-Dipeptidase A; Renin-Angiotensin System; SARS-CoV-2 | 2023 |
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Topics: Age Factors; Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Cardiovascular Diseases; Coronavirus Infections; COVID-19; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Prognosis; Proto-Oncogene Mas; Receptor, Angiotensin, Type 1; Receptors, Virus; SARS-CoV-2; Sex Factors; Signal Transduction; Spike Glycoprotein, Coronavirus | 2020 |
Potential influence of COVID-19/ACE2 on the female reproductive system.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Gene Expression Regulation; Genitalia, Female; Host-Pathogen Interactions; Humans; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pregnancy; Protein Binding; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2020 |
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azetidines; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Progression; Gene Expression Regulation; Host-Pathogen Interactions; Humans; Janus Kinases; Methotrexate; Molecular Targeted Therapy; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Purines; Pyrazoles; Receptor, Angiotensin, Type 1; SARS-CoV-2; Signal Transduction; STAT Transcription Factors; Sulfonamides | 2020 |
Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Neprilysin; Pandemics; Peptide Fragments; Pneumonia, Viral; SARS-CoV-2; Signal Transduction | 2020 |
Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID-19?
Topics: Acetates; Angiotensin I; Animals; Annexin A1; Anti-Inflammatory Agents; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal; Docosahexaenoic Acids; Humans; Hydrogen Peroxide; Inflammation; Inflammation Mediators; Mice; Orthomyxoviridae Infections; Oxidants; Peptide Fragments; Peptides; Phosphodiesterase 4 Inhibitors; Pneumonia, Viral; Rolipram; Vasodilator Agents | 2020 |
A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Coronavirus Infections; COVID-19; Gene Expression Regulation; Humans; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Binding; Proto-Oncogene Mas; Receptor, Angiotensin, Type 1; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2; Severity of Illness Index; Spike Glycoprotein, Coronavirus; Vitamin D | 2020 |
SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Inflammation; Interleukin-6; Macrophages; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2 | 2020 |
The Controversy of Renin-Angiotensin-System Blocker Facilitation Versus Countering COVID-19 Infection.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Coronavirus Infections; COVID-19; Humans; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Recombinant Proteins; Renin-Angiotensin System; Spike Glycoprotein, Coronavirus | 2020 |
ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; COVID-19; Humans; Muscle, Skeletal; Peptide Fragments; SARS-CoV-2 | 2020 |
Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Comorbidity; COVID-19; Humans; Hypertension; JNK Mitogen-Activated Protein Kinases; Lung; MAP Kinase Signaling System; Peptide Fragments; Protective Factors; Receptors, Coronavirus; Renin-Angiotensin System; Risk Factors; SARS-CoV-2; Up-Regulation | 2020 |
Potential detrimental role of soluble ACE2 in severe COVID-19 comorbid patients.
Topics: ADAM17 Protein; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Comorbidity; COVID-19; Humans; Peptide Fragments; SARS-CoV-2 | 2021 |
ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Vessels; COVID-19; Humans; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Renin-Angiotensin System; SARS-CoV-2; Vascular Diseases | 2021 |
Cardiovascular Outcomes in the Acute Phase of COVID-19.
Topics: Acute Disease; Angiotensin I; Angiotensin-Converting Enzyme 2; Arteries; Cardiovascular Diseases; COVID-19; Humans; Morbidity; Peptide Fragments; Vascular Stiffness | 2021 |
The angiotensin converting enzyme 2 (ACE2) system in the brain: possible involvement in Neuro-Covid.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Brain; COVID-19; Humans; Nervous System Diseases; Peptide Fragments; Proto-Oncogene Mas; Receptors, G-Protein-Coupled | 2021 |
Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
Topics: ADAM17 Protein; Angiotensin I; Angiotensin-Converting Enzyme 2; COVID-19; COVID-19 Drug Treatment; Gene Expression Regulation, Enzymologic; Humans; Peptide Fragments; Renin-Angiotensin System; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Up-Regulation | 2021 |
1 trial(s) available for angiotensin ii, des-phe(8)- and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1-7 (TXA-127) for the treatment of severe COVID-19.
Topics: Angiotensin I; Antifibrinolytic Agents; Blood Loss, Surgical; COVID-19; Double-Blind Method; Humans; Peptide Fragments; Pilot Projects; Tranexamic Acid; Treatment Outcome | 2022 |
21 other study(ies) available for angiotensin ii, des-phe(8)- and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
Topics: ADAM17 Protein; Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Enzyme Activation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Peptide Fragments; Prognosis; Prospective Studies; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Renin-Angiotensin System; Respiration, Artificial; Risk; SARS-CoV-2; Treatment Outcome | 2022 |
Angiotensin (1-7) peptide replacement therapy with plasma transfusion in COVID-19.
Topics: Adult; Aged, 80 and over; Angiotensin I; Blood Component Transfusion; COVID-19; Critical Illness; Female; Humans; Male; Oxygen; Peptide Fragments; Plasma; SARS-CoV-2; Treatment Outcome | 2022 |
Angiotensin 1-7 Stimulates Proliferation of Lung Bronchoalveolar Progenitors-Implications for SARS-CoV-2 Infection.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cell Proliferation; COVID-19; Inflammasomes; Lung; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Fragments; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Respiratory Distress Syndrome; SARS-CoV-2 | 2022 |
Unveiling the G4-PAMAM capacity to bind and protect Ang-(1-7) bioactive peptide by molecular dynamics simulations.
Topics: Amino Acids; Angiotensin I; COVID-19; Dendrimers; Humans; Molecular Dynamics Simulation; Peptide Fragments; Peptides | 2022 |
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials.
Topics: Adult; Angiotensin II; Angiotensins; COVID-19; Female; Humans; Hypoxia; Infusions, Intravenous; Ligands; Male; Middle Aged; Oligopeptides; Randomized Controlled Trials as Topic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; SARS-CoV-2; Vasodilator Agents | 2023 |
Altered renin-angiotensin system gene expression in airways of antigen-challenged mice: ACE2 downregulation and unexpected increase in angiotensin 1-7.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Asthma; COVID-19; Down-Regulation; Gene Expression; Mice; Ovalbumin; Renin-Angiotensin System; SARS-CoV-2 | 2023 |
Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Lung; Lung Injury; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Exercise as medicine for COVID-19: An ACE in the hole?
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Susceptibility; Exercise; Host Microbial Interactions; Humans; Models, Biological; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Receptors, Virus; SARS-CoV-2 | 2020 |
The renin-angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Coagulation Disorders; Coronavirus Infections; COVID-19; Cytokines; Humans; Hypertension; Lung; Lung Diseases; Obesity; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptor, Angiotensin, Type 1; Severity of Illness Index | 2020 |
Apelin-potential therapy for COVID-19?
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Apelin; Apelin Receptors; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Mice; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; SARS-CoV-2 | 2020 |
SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
Topics: Alveolar Epithelial Cells; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Host Microbial Interactions; Humans; Lung; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pulmonary Fibrosis; Receptors, Coronavirus; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2; Transforming Growth Factor beta | 2020 |
Angiotensin-(1-7) and Obesity: Role in Cardiorespiratory Fitness and COVID-19 Implications.
Topics: Angiotensin I; Betacoronavirus; Cardiorespiratory Fitness; Coronavirus Infections; COVID-19; Humans; Infections; Obesity; Pandemics; Peptide Fragments; Pneumonia, Viral; SARS-CoV-2 | 2020 |
COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2 | 2020 |
COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Anticoagulants; Cardiovascular Diseases; COVID-19; Humans; Hypertension; Models, Theoretical; Peptide Fragments; Renin-Angiotensin System; Respiration; Risk Factors; Venous Thromboembolism; Virus Internalization | 2020 |
Lung ACE2 and ADAM17 in pulmonary arterial hypertension: Implications for COVID-19?
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pulmonary Arterial Hypertension; SARS-CoV-2 | 2020 |
COVID-19: Underlying Adipokine Storm and Angiotensin 1-7 Umbrella.
Topics: Adipokines; Angiotensin I; Angiotensin-Converting Enzyme 2; Betacoronavirus; Coronavirus Infections; COVID-19; Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; Obesity; Pandemics; Peptide Fragments; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2; Severe Acute Respiratory Syndrome | 2020 |
Coronavirus disease 2019 is associated with low circulating plasma levels of angiotensin 1 and angiotensin 1,7.
Topics: Angiotensin I; COVID-19; Female; Humans; Male; Peptide Fragments | 2021 |
Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Computer Simulation; COVID-19; COVID-19 Drug Treatment; Humans; Models, Theoretical; Peptide Fragments; Renin; Renin-Angiotensin System; SARS-CoV-2; Viral Load | 2020 |
Concerns on the Specificity of Commercial ELISAs for the Measurement of Angiotensin (1-7) and Angiotensin II in Human Plasma.
Topics: Angiotensin I; Angiotensin II; Chromatography, Agarose; COVID-19; Enzyme-Linked Immunosorbent Assay; Humans; Peptide Fragments; Radioimmunoassay; Reference Standards; Renin-Angiotensin System; SARS-CoV-2; Sensitivity and Specificity; Specimen Handling | 2021 |
Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; COVID-19; Female; Humans; Male; Middle Aged; Peptide Fragments; Peptidyl-Dipeptidase A; Prospective Studies; Renin; Renin-Angiotensin System; SARS-CoV-2 | 2021 |
Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Female; Gene Expression Profiling; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Peptide Fragments; Pilot Projects; Prospective Studies; RNA, Messenger; Virus Shedding | 2021 |